An Open-label Study Of MDX-010 In Combination With gp100 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Stage IV Melanoma
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Ipilimumab (Primary) ; MDX 1379 (Primary) ; Montanide ISA-51
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.